Clinical Efficacy of Dofetilide for the Treatment of Atrial Tachyarrhythmias in Adults with Congenital Heart Disease

Autor: Erica Penny-Peterson, Javier E. Banchs, Gerald V. Naccarelli, William R. Davidson, Mario D. Gonzalez, Deborah L. Wolbrette, Michelle J. Nickolaus, John Kelleman, Soraya Samii, Sallie K. Young, Jennifer Grando-Ting, Giselle A. Baquero

Publikováno v: Congenital Heart Disease. 9:221-227

Background Atrial tachyarrhythmias (AT) including atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia represent a clinical challenge in the adult with congenital heart disease (CHD). Dofetilide (D) is a rapidly activating delayed r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60330b37d7b11cd84e49e7c0ae6ba025
https://doi.org/10.1111/chd.12129

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter

Autor: Erica Penny-Peterson, Mario D. Gonzalez, Vadim Levin, Soraya Samii, Deborah L. Wolbrette, Gerald V. Naccarelli, Javier E. Banchs

Publikováno v: Clinical Medicine Insights: Cardiology, Vol 2011, Iss 5, Pp 103-119 (2011)
Clinical Medicine Insights: Cardiology, Vol 5 (2011)
Clinical Medicine Insights. Cardiology

Dronedarone is an amiodarone analog but differs structurally from amiodarone in that the iodine moiety was removed and a methane-sulfonyl group was added. These modifications reduced thyroid and other end-organ adverse effects and makes dronedarone l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef022c613dfb50b5004d830111644d3f
http://www.la-press.com/safety-and-efficacy-of-dronedarone-in-the-treatment-of-atrial-fibrilla-a2866

Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter

Autor: Parag P. Patel, Soraya Samii, Sallie K. Young, Mario D. Gonzalez, Gerald V. Naccarelli, Javier E. Banchs, Erica Penny-Peterson, Deborah L. Wolbrette

Publikováno v: Journal of Interventional Cardiac Electrophysiology. 23:111-115

Dofetilide, an IKr blocker has been demonstrated to be effective in terminating persistent atrial fibrillation and flutter (AF/AFL), and in maintaining sinus rhythm after direct current cardioversion (CV). It is not known, however, whether pharmacolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774c1a0154e048d3e3c1e5c921fdc283
https://doi.org/10.1007/s10840-008-9290-6

Atrial Fibrillation—New Antiarrhythmic Drugs

Autor: Mario D Gonzalez, Robert Stevenson, Erica Penny-Peterson, Javier E Banchs, Soraya Samii, Deborah L Wolbrette, Gerald V Naccarelli

Publikováno v: US Cardiology Review. 4:71-73

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::699a06dd62c7c8ab2c78e71eb61c5bfd
https://doi.org/10.15420/usc.2007.4.2.71

Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads

Autor: Mario D. Gonzalez, Erica Penny-Peterson, Giselle A. Baquero, Joshua B. Skibba, Latoya Linton-Frazier, Deborah L. Wolbrette, Eugene J. Lengerich, Soraya Samii, Gerald V. Naccarelli, Pradeep Yadav, Jerry C. Luck, Javier E. Banchs

Publikováno v: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 38(3)

Cardiac rhythm management devices (CRMD) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an under-recognized clinical complication of lead implantation and its clinical significance is unknown. We s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061956f9c45cf201f7e38a8a80f741e5
https://pubmed.ncbi.nlm.nih.gov/24022757